ロード中...
The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial
INTRODUCTION: In immunocompromised patients, acute respiratory failure (ARF) is associated with high mortality, particularly when invasive mechanical ventilation (IMV) is required. In patients with severe hypoxemia, high-flow nasal oxygen (HFNO) therapy has been used as an alternative to delivery of...
保存先:
| 出版年: | Crit Care |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4629403/ https://ncbi.nlm.nih.gov/pubmed/26521922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-1097-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|